The selection of naturally stable candidate foot-and-mouth disease virus vaccine strains for East Africa.

Jackson, Ben; Harvey, Yongjie; Perez-Martin, Eva; Wilsden, Ginette; Juleff, Nicholas; Charleston, Bryan; Seago, Julian

Jackson, Ben; Harvey, Yongjie; Perez-Martin, Eva; Wilsden, Ginette; Juleff, Nicholas; Charleston, Bryan; Seago, Julian.

Afiliação

Jackson B; The Pirbright Institute, Woking, Surrey GU24 0NF, United Kingdom.
Harvey Y; The Pirbright Institute, Woking, Surrey GU24 0NF, United Kingdom.
Perez-Martin E; The Pirbright Institute, Woking, Surrey GU24 0NF, United Kingdom.
Wilsden G; The Pirbright Institute, Woking, Surrey GU24 0NF, United Kingdom.
Juleff N; Bill & Melinda Gates Foundation, 500 5th Ave N, Seattle, WA 98109, United States.
Charleston B; The Pirbright Institute, Woking, Surrey GU24 0NF, United Kingdom.
Seago J; The Pirbright Institute, Woking, Surrey GU24 0NF, United Kingdom. Electronic address: julian.seago@pirbright.ac.uk.

Vaccine ; 39(35): 5015-5024, 2021 08 16.

Article em En | MEDLINE | ID: mdl-34303562

Assuntos

Vírus da Febre Aftosa; Febre Aftosa; Vacinas Virais; Animais; Proteínas do Capsídeo/genética; Febre Aftosa/prevenção & controle; Sorogrupo

Palavras-chave

FMD vaccine; Foot-and-mouth disease; Foot-and-mouth disease virus; Strain stability; Virus neutralisation test

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Vacinas Virais / Vírus da Febre Aftosa / Febre Aftosa Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Vaccine Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google